-
US woman who survived botched execution is awake and speaking
-
Russia's plague scare: What we know
-
From 1800s to modern pharma: a Nobel-winning chemistry quest
-
French luxury giant to fund redevelopment of two Paris streets: city hall
-
Southampton boss Eckert given suspended ban over 'Spygate'
-
Trump wants to turn Florida golf course into presidential retreat
-
Russia warns of 'false' information as second plague case reported
-
Mayor of Turkish opposition stronghold defects to Erdogan party
-
IEA ready to release more oil reserves if necessary
-
Children among heavy casualties in Ukraine after Russian strikes
-
HSBC 'consults' over UK unit job cuts amid AI adoption
-
Court orders German ex-spy chief kept in jail after spying, treason arrest
-
UK court quashes five ex-traders' Libor rate rigging convictions
-
Guinea caps bottled water prices after sachets banned
-
XM Receives “Global Customer Experience Leader Award 2026” at the TrustFinance Performance Awards
-
Spared, married, hanged: the last weeks of Iranian protester Alireza Sepahi
-
Stocks slide as oil climbs on Mideast flareup
-
Nobel physics winner's pride at pioneering AI role
-
Heavy casualties in Ukraine after Russian strikes
-
IMF preparing El Nino assistance, concerned about AI bubble burst: chief to AFP
-
French wine harvest set to hit historic low
-
West must embrace 'national power' or face decline: Rubio
-
Kyiv 'cannot agree' to EU membership limiting food exports: minister
-
Shell refining margins reach record highs as wars hit supply
-
Arteta targets more Arsenal glory after signing new deal until 2030
-
Former Spain, Barca winger Pedro retires from football
-
Russell hit with Singapore grid penalty for taking new power unit
-
Arteta signs new Arsenal deal until 2030
-
Spotify expands audiobooks to more than 180 markets
-
Stocks decline as oil climbs on Mideast flareup
-
French-Japanese duo wins chemistry Nobel for solving molecular 'mystery'
-
Gauff says online abuse was 'draining' after China Open exit
-
England's Nations League surge helps heal World Cup wounds
-
As sector struggles, Porsche puts luxury ahead of volume
-
Mayor of opposition stronghold Izmir defects to Erdogan party
-
'It's personal': Fiji minister pushes better climate finance at pre-COP
-
Mertens beats Gauff to set up Swiatek clash at China Open
-
Russia glosses over dark Soviet past in reinvented museum
-
Benin full of pride at role in Messi's last dance
-
UK tax body opened probe into Man City in 2018: FT
-
France suspends stun grenade use at student protests ahead of PM speech
-
Yemen's Houthis claim new attacks on Saudi airports as conflict deepens
-
Indonesian court hears 'negligence' complaint against state over fires, haze
-
Germany factory production at highest level for 18 months
-
Rubio in Greece to urge against Western civilisation 'decline'
-
Thailand floods death toll rises to 60 since mid-September
-
Micron workers at Taiwan plant vote in favour of strike
-
US pushes Russia for information on plague reports
-
In 'The Social Reckoning,' Jeremy Allen White takes on Facebook's 'frightening' ambition
-
Myanmar leader lands in Malaysia for migrant return talks
Long Covid symptoms affect one in eight, study suggests
One in eight people who get coronavirus develop at least one symptom of long Covid, one of the most comprehensive studies on the condition to date suggested on Thursday.
With more than half a billion coronavirus cases recorded worldwide since the start of the pandemic, there has been rising concern about the lasting symptoms seen in people with long Covid.
However almost none of the existing research has compared long Covid sufferers with people who have never been infected, making it possible that some of the health problems were not caused by the virus.
A new study published in The Lancet journal asked more than 76,400 adults in the Netherlands to fill out an online questionnaire on 23 common long Covid symptoms.
Between March 2020 and August 2021, each participant filled out the questionnaire 24 times.
During that period, more than 4,200 of them -- 5.5 percent -- reported catching Covid.
Of those with Covid, over 21 percent had at least one new or severely increased symptom three to five months after becoming infected.
However nearly nine percent of a control group which did not have Covid reported a similar increase.
This suggested that 12.7 percent of those who had Covid -- around one in eight -- suffered from long-term symptoms, the study said.
The research also recorded symptoms before and after Covid infection, allowing the researchers to further pinpoint exactly what was related to the virus.
It found that common long Covid symptoms include chest pain, breathing difficulties, muscle pain, loss of taste and smell, and general fatigue.
- 'Major advance' -
One of the study's authors, Aranka Ballering of the Dutch University of Groningen, said long Covid was "an urgent problem with a mounting human toll".
"By looking at symptoms in an uninfected control group and in individuals both before and after SARS-CoV-2 infection, we were able to account for symptoms which may have been a result of non-infectious disease health aspects of the pandemic, such as stress caused by restrictions and uncertainty," she said.
The authors of the study said its limitations included that it did not cover later variants, such as Delta or Omicron, and did not collect information about some symptoms such as brain fog, which have since been considered a common sign of long Covid.
Another study author, Judith Rosmalen, said "future research should include mental health symptoms" such as depression and anxiety, as well as aspects like brain fog, insomnia and a feeling of malaise after even minor exertion.
Christopher Brightling and Rachael Evans, experts from Britain's Leicester University who were not involved in the study, said it was "a major advance" on previous long Covid research because it had an uninfected control group.
"Encouragingly, emerging data from other studies" suggests there is a lower rate of long Covid in people who have been vaccinated or infected with the Omicron variant, they said in a linked Lancet comment.
D.AbuRida--SF-PST